Approval · Notice of Compliance 7414 · 2005
INOMAX: Notice of Compliance 7414
Issued September 23, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7414
- Date
- September 23, 2005
- Company
- Ino TherapeuticsBridgewater, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Pulmonary vasodilator
Products in this notice
Medicinal ingredients
- NITRIC OXIDE 100 PPM per CYLR
- NITRIC OXIDE 800 PPM per CYLR